On February 7th, 2018, SIU London welcomed two speakers from King's College London, Prof Thais Russomano & Prof. Stephen Harridge, who both have research fields that cross on the topic of the human condition in space flight. Read here to discover what was shared on the medical challenges faced in microgravity, how these are being overcome, and the value of these studies for terrestrial medicine.
Diabetes is one of the top deadly diseases in the world. Innovation in health tech is addressing the need for better ways to monitor and manage blood glucose levels. Read on here for updates on how wearable tech and AI are being applied to diabetes patients....
On January 25th, 2018 SIU Frankfurt hosted a highly attended event on alternative careers in big pharma and biotech. Dr. Jens Atzrodt, Karin Messer and Dr. José Airas were our guest speakers, who have leading roles in R&D, Human Resources and Consultancy at Sanofi Germany and Merck respectively. Read on for their advice to early career scientists open to pursuing careers in industry...
Dr. José Airas, a Director of Inhouse Consulting at Merck KGaA, is scheduled to speak at SIU's “Academic Breakout: Alternative Careers in Biotech” on January 25th, 2018 in Frankfurt am Main. Here, he gives us a preview of advice on transitioning from academia to industry ahead of his talk.
Is there a link between depression and inflammation in the brain? And what could this discovery mean for treating depression? Read on for more insights on the connection between the immune system and mental health.
Dr. Bert Sakmann, MD, PhD was a guest speaker at our SIU Katowice event the 'Brain in a nutshell'. Here, we have an exclusive interview with the Nobel Laureate in Medicine and Physiology (1991). He discusses the challenges leading up to his award winning work on cellular ion channels , explains his current research on digital neuroanatomy at the Max Planck Institute and offers his opinion on Artificial Intelligence.
Mr Paweł Soluch is the CEO of the Neuro Device Group, a company that has built a strong portfolio of biomedical products to address demand in the scientific market for new equipment and to attempt to solve ideologies where research has otherwise failed. Here he gives us insight into the medtech field and shares his experience as both a scientist and entrepreneur.
Prof. Dobson is currently the Principal Fellow at Warwick Manufacturing Group, University of Warwick, has visiting professorships at UCL and King’s College, London and was previously the Academic Director of the Begbroke Science Park at the University of Oxford. In this interview, he has shared his expert opinion on the biotechnology research and policy landscape, and redefines the hard lessons for innovators.
On November 30, 2017 the SIU Katowice team held a successful “The Brain in a Nutshell” event - amassing an interest in over 200 attendees. Understanding the brain is exceedingly important as it steers the very essence of life itself; and with this in mind, the SIU team welcomed three guest speakers to discuss current brain research and the vast possibilities that could come about from increasing our understanding of the brain.
Pneumonia affects hundreds of millions of people a year around the world and early detection of the disease is one of the most important preventative measures to bring the numbers down. CheXNet, a deep learning algorithm developed by scientists in Stanford, is one of the methods we can utilise machine learning for early detection of pneumonia.
Cell free fetal DNA (cffDNA) circulating in maternal blood was discovered back in 1997. It now shows promise in being used for non-invasive pre-natal screening to detect fetal chromosomal abnormalities and more. Read here for insights on the efficacy and advantages of this technique.
As part of our SIU Conference series, the Oxford division hosted three speakers at the ‘Neurotechnology and Applied Neuroscience’ event on 23rd November 2017 at Magdalen College, a primary sponsor of SIUOxford. Our speakers were selected based on their shared experience of utilising some aspect of applied neuroscience for social and/or commercial impact.
On November 20th in Frankfurt the SIU team welcomed Prof Gregory Wheeler and Prof Roberto V. Zicari to our SIUTranslations event to talk about Artificial Intelligence and its human side. Read on to find out what these experts discussed with our audience at this high-impact event.
The ongoing healthcare system crisis in Poland and the accompanying protests and hunger strikes that started recently concern the healthcare professionals in the country greatly. At our SIUConversations event that took place in Katowice on November 17 we addressed the questions and possible answers to the the problem with our three panellists.
On November 16, 2017, the London Division of the SIU organised a workshop with Dr Jeff Skinner, the Executive Director of the Institute of Innovation and Entrepreneurship at London Business School on commercial strategy. The main focus was on what it means to develop a commercial strategy for a researcher and if it is actually needed when the underlying technology is compelling enough to sell itself.
SIUOxford hosted our first educational event for this academic year on November 16th 2017, titled ‘Academia and Industry: Advancing Science and Your Career’. We welcomed three professionals, all with experience in both academia and industry, to share their career journeys and to offer advice to attendees on how to approach bridging the gap between the two areas.
Stroke is considered a pandemic because of the number of people affected every year around the world. Complications arising from methods traditionally used in treatment of blockage of arteries - an underlying cause - have led to the birth of TransCarotid Artery Revascularisation (TCAR) method. This article brings you all you want to know about this promising innovation.
On November 13, 2017, The Oxford Division of the SIU collaborated with Enterprising Oxford to host the CEO and co-founder of Labstep, Jake Schofield. The event was part of the #StartedinOxford series that highlights startups that were founded in the Oxford ecosystem. Here is the summary of the illuminating talk.
It is a common struggle for many aspiring scientists to gain knowledge and support to commercialise their scientific ideas. We interviewed Dr Jeff Skinner, the Executive Director of the Institute of Innovation and Entrepreneurship at London Business School (LBS).
We all find one way or another to enhance our daily performance. What is the biology behind the methods we use? How do these methods affect healthy versus unhealthy individuals? In this article we bring you all you need to know about neuroenhancement.